October 30, 2024
Save
VIDEO: SOD1 gene shows ‘great promise’ in ALS treatment
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
In this video, Alokkumar Jha, PhD, MSc, BE, spoke with Healio about treating patients with ALS with a mutation in the superoxide dismutase 1, or SOD1 gene.
Jha noted that tofersen, an FDA-approved treatment, shows "great promise" in the research of ALS and its genetic causes.